Enjo Satoko, Hazama Yutaro, Kimura Soichiro, Morimoto Yasunori, Ueda Hideo
Department of Hospital Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan.
J Adv Pharm Technol Res. 2023 Apr-Jun;14(2):94-98. doi: 10.4103/japtr.japtr_647_22. Epub 2023 Apr 13.
In this study, we investigated whether stimulating the skin with ultrasound (US) could activate Langerhans cells (LCs) - antigen-presenting cells in the epidermis and stimulate antibody production following the subcutaneous and intradermal injection of ovalbumin (OVA) in hairless rats and BALB/c mice. Three different US frequencies (20 kHz, 1, and 3 MHz) were used and the expression of langerin was monitored as a marker for the activation of LCs in the epidermal sheet. In hairless rats, the langerin signal peaked at 12 h post-US treatment and returned to control levels at 24 h. Its expression increased with increasing irradiation time, up to 20 min, and 20 kHz US induced the highest langerin expression among the three frequencies tested. These results were reproduced in BALB/c mice. When the skin was pretreated with 20 kHz US at 0.41 W/cm for 10 min, the production of OVA-specific immunoglobulin G1 in mice increased by 2.8- and 3.4-fold 28 days after subcutaneous or intradermal OVA injections, respectively. These findings indicate that stimulating the skin with US can trigger skin immune responses, leading to effective antigen-specific antibody production. US-assisted transdermal vaccine delivery delivers antigens to the skin and evokes an immune response, providing an effective noninvasive immunization strategy.
在本研究中,我们调查了用超声(US)刺激皮肤是否能激活无毛大鼠和BALB/c小鼠表皮中的朗格汉斯细胞(LCs)——抗原呈递细胞,并在皮下和皮内注射卵清蛋白(OVA)后刺激抗体产生。使用了三种不同的超声频率(20 kHz、1 MHz和3 MHz),并监测了朗格蛋白的表达,作为表皮片中LCs激活的标志物。在无毛大鼠中,朗格蛋白信号在超声治疗后12小时达到峰值,并在24小时恢复到对照水平。其表达随照射时间增加而增加,最长可达20分钟,并且在测试的三种频率中,20 kHz超声诱导的朗格蛋白表达最高。这些结果在BALB/c小鼠中得到了重现。当皮肤用0.41 W/cm的20 kHz超声预处理10分钟时,在皮下或皮内注射OVA 28天后,小鼠中OVA特异性免疫球蛋白G1的产生分别增加了2.8倍和3.4倍。这些发现表明,用超声刺激皮肤可以触发皮肤免疫反应,导致有效的抗原特异性抗体产生。超声辅助透皮疫苗递送将抗原递送至皮肤并引发免疫反应,提供了一种有效的非侵入性免疫策略。